← Browse by Condition
Medical Condition

leukemia

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
NCT06501196 Phase 1
Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
View Trial →
NCT07356154 Phase 1, Phase 2
Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT07249346 Phase 2
Recruiting

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Enrollment
124 pts
Location
United States
Sponsor
Hannah Choe, MD
View Trial →
NCT06839456 Phase 1, Phase 2
Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Enrollment
100 pts
Location
United States
Sponsor
Children's Hospital of Philade...
View Trial →
NCT06131801
Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
View Trial →
NCT01515527 Phase 2
Recruiting

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Enrollment
160 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07105579 Phase 2
Recruiting

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

Enrollment
31 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
View Trial →
NCT06800586
Recruiting

Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects

Enrollment
300 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT06824168 Phase 2
Recruiting

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Enrollment
130 pts
Location
United States, Austr...
Sponsor
Daiichi Sankyo
View Trial →
NCT05062707
Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT06353698
Recruiting

Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia

Enrollment
40 pts
Location
Iran
Sponsor
National Nutrition and Food Te...
View Trial →
NCT05190653
Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

Enrollment
152 pts
Location
Canada
Sponsor
Alberta Health Services, Calga...
View Trial →
NCT00935090
Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
View Trial →
NCT07086989
Recruiting

Cardiovascular Risk in Children With Chronic Conditions Study

Enrollment
300 pts
Location
Hungary
Sponsor
Semmelweis University
View Trial →
NCT07202091 Phase 2, Phase 3
Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

Enrollment
900 pts
Location
Australia
Sponsor
Monash University
View Trial →